
Upheal is an AI-powered platform designed for mental health providers, including individual practitioners, group practices, and virtual care providers. It automates the creation of clinical progress notes, treatment plans, and session analytics, allowing professionals to save time and focus more on their clients. The platform supports various session capture methods (in-person, online calling platforms, or its own app) and offers features like note customization, multi-language support, and secure data handling compliant with HIPAA, PHIPA, PIPEDA, and GDPR, as well as SOC 2 Type II certification. Upheal aims to reduce provider burnout and improve the quality of care by streamlining administrative tasks.

Upheal is an AI-powered platform designed for mental health providers, including individual practitioners, group practices, and virtual care providers. It automates the creation of clinical progress notes, treatment plans, and session analytics, allowing professionals to save time and focus more on their clients. The platform supports various session capture methods (in-person, online calling platforms, or its own app) and offers features like note customization, multi-language support, and secure data handling compliant with HIPAA, PHIPA, PIPEDA, and GDPR, as well as SOC 2 Type II certification. Upheal aims to reduce provider burnout and improve the quality of care by streamlining administrative tasks.
What they do: AI-powered progress notes and session analytics platform for mental health clinicians
Founders & founding year: Co-founded by Juraj Chrappa and Martin Horvath; founded in 2021
Latest raise: $10M Series A announced Nov 2024 (total funding stated as $14.35M)
Compliance & use case: Positions itself as HIPAA- and GDPR-compliant; targets clinician burnout reduction and documentation automation
Clinical documentation and practice analytics for mental health providers
2021
Healthtech / Mental health software
$1.05M
Participation from Credo Ventures and Calm/Storm Ventures; named angel investors include Juraj Masar, Javier Suarez, Andrej Kiska, Tomas Scavnicky, Peter Zajac, and Anton Zajac (per company disclosure).
$3.25M
Company-stated seed round with angel participation including Martin Viecha and Aakash Desai (per company disclosure).
$10M
Company-stated Series A with participation from Credo Ventures and Kaya Ventures; company stated this brought total funding to $14.35M.
“Backed by institutional VCs across rounds (Headline led Series A; Credo Ventures led Seed; KAYA VC led Pre-seed) with participation from additional firms (Kaya/KAYA, Calm/Storm Ventures, Inovia listed in some profiles) and multiple angel investors.”